Funding opportunity for cancer research innovations in statistical methods, epidemiology, survivorship, behaviors, healthcare, and implementation.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing)
Funding Amounts: Up to $250,000 in direct costs annually, excluding consortium F&A costs, for up to 5 years
Summary: Supports cancer control and population sciences research advancing methods, epidemiology, behavior, healthcare delivery, survivorship, digital health, and implementation science.
Key Information: Basic cancer biology and development of novel cancer diagnostics or therapies are not responsive and will not be reviewed.
The National Cancer Institute (NCI), through its Division of Cancer Control and Population Sciences (DCCPS), supports R01 research on novel scientific ideas with potential to substantially advance cancer control and population sciences. The program emphasizes scientific challenges suited to reduced budgets and shorter time spans, while encouraging early-stage investigators and expanding their participation in the R01 portfolio. Applications may propose clinical trials, but trials are not required.
The research scope includes statistical and analytic methods, cancer surveillance informatics, environmental and genomic epidemiology, systems modeling, behavioral research, healthcare delivery, cancer survivorship, digital health and data science, and implementation science. DCCPS seeks to reduce cancer risk, incidence, and deaths and improve survivors’ quality of life through research on cancer causes and distribution, effective interventions, and cancer trends across populations.